SCI Abstract

search
+
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions
BiCNU (carmustine), etoposide, Ara-C, melphalan (BEAM) and Campath conditioning was developed to reduce the high transplan...
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
Volume 26, Issue 12, December 2020, Pages 2279-2284Author links open overlay panel, , , , , Highlights•Late relapse after ...
Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major
Graft-versus-host disease (GVHD) is an important challenge and a major cause of morbidity and mortality in children after ...
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India
Peripheral blood stem cells provide early engraftment, decreasing the risk of prolonged neutropenia and sepsis, with a foc...
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a valid option in patients with refractory lymphomas. HLA...
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Volume 26, Issue 12, December 2020, Pages 2306-2310Author links open overlay panel, , , , , , , , , , , , , , , , , Highli...
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
Severe aplastic anemia (SAA) is a life-threatening disease that can be cured with allogeneic cell transplantation (HCT). H...
Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic
The pulmonary function test (PFT) is an important test for risk stratification before allogeneic transplantation (allo-HCT...
Clinical and Neuroimaging Correlates of Post-Transplant Delirium
Delirium is common among adults undergoing hematopoietic stem cell transplantation (HCT), although the clinical and neuroi...
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients
The use of potentially inappropriate medications (PIMs) using Beers criteria and its impact on older allogeneic hematopoie...
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
Hematopoietic cell transplantation (HCT) is an effective treatment for many hematologic malignancies, and its utilization ...
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group
Volume 26, Issue 12, December 2020, Pages 2346-2358Author links open overlay panel, , , , , , , , , , , , , , , , , , , …H...
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study
Volume 26, Issue 12, December 2020, Pages 2359-2364Author links open overlay panel, , , Highlights•Empiric granulocyte col...
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
Volume 26, Issue 12, December 2020, Pages 2365-2371Author links open overlay panel, , , , , , , , , , , , , , , , , Highli...
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study
Multiple myeloma (MM) is a plasma cell neoplasm characterized by destructive bony lesions, anemia, and renal impairment. A...
Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study
Volume 26, Issue 12, December 2020, Pages e316-e321Author links open overlay panel, , , , , , , Highlights•Individuals wit...
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia
Volume 26, Issue 12, December 2020, Pages e322-e327Author links open overlay panel, , , , , , , , , , , , , , , , Highligh...
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
Volume 26, Issue 12, December 2020, Pages e328-e332Author links open overlay panel, , , , , , , , , , , , , , Highlights•A...
Letter to the Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
Volume 26, Issue 12, December 2020, Pages e333-e334Author links open overlay panelJie Zhang 1, Junlong Li 2, Qiufei Ma 2, ...
Response to Letter to Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
Volume 26, Issue 12, December 2020, Pages e335-e336Author links open overlay panelOlalekan O. Oluwole 1, Jeroen P. Jansen ...
format_indent_increase